logo

Adma Biologics, Inc. (ADMA)



Trade ADMA now with
  Date
  Headline
7/26/2018 7:59:48 AM ADMA Biologics Gets PDUFA Date For BIVIGAM Regulatory Submission; Target Action Date For PAS Is Oct. 25, 2018
6/12/2018 4:08:52 PM ADMA Biologics Closes $40 Mln Public Offering
6/8/2018 9:10:01 AM ADMA Biologics Prices Public Offering Of 8.37 Mln Shares At $4.78/Shr
6/7/2018 4:11:33 PM ADMA Biologics Announces Proposed Public Offering Of Common Stock
5/16/2018 7:32:20 AM ADMA Biologics Granted U.S. Patent For Treating Respiratory Infections
3/5/2018 7:07:18 AM ADMA Biologics FY Total Revenues $22.8 Mln Vs $10.7 Mln Last Year